Search Results - "Steve Quiros"

Refine Results
  1. 1

    Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells by Berdelle, Nicole, Nikolova, Teodora, Quiros, Steve, Efferth, Thomas, Kaina, Bernd

    Published in Molecular cancer therapeutics (01-12-2011)
    “…Artesunate, the active agent from Artemisia annua L. used in the traditional Chinese medicine, is being applied as a first-line drug for malaria treatment, and…”
    Get full text
    Journal Article
  2. 2

    Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs by Quiros, Steve, Roos, Wynand Paul, Kaina, Bernd

    Published in PloS one (02-11-2011)
    “…First line chemotherapeutics for brain tumors (malignant gliomas) are alkylating agents such as temozolomide and nimustine. Despite growing knowledge of how…”
    Get full text
    Journal Article
  3. 3

    Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage by Knizhnik, Anna V, Roos, Wynand P, Nikolova, Teodora, Quiros, Steve, Tomaszowski, Karl-Heinz, Christmann, Markus, Kaina, Bernd

    Published in PloS one (30-01-2013)
    “…Apoptosis, autophagy, necrosis and cellular senescence are key responses of cells that were exposed to genotoxicants. The types of DNA damage triggering these…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Sphingolipid pathway as a biosensor of cancer chemosensitivity: a proof of principle by José Arturo Molina-Mora, Susana Mesen-Porras, Isaac Quiros-Fernandez, Mariana Kop-Montero, Andrea Rojas-Cespedes, Steve Quiros, Francisco Siles, Rodrigo Mora

    Published in Uniciencia (01-11-2022)
    “…Cancer is a complex genetic disease with reduced treatment alternatives due to tumor heterogeneity and drug multiresistance emergence. The sphingolipid (SL)…”
    Get full text
    Journal Article
  6. 6

    Sphingolipid-Based Synergistic Interactions to Enhance Chemosensitivity in Lung Cancer Cells by Mesén-Porras, Susana, Rojas-Céspedes, Andrea, Molina-Mora, José Arturo, Vega-Baudrit, José, Siles, Francisco, Quiros, Steve, Mora-Rodríguez, Rodrigo

    Published in Cells (Basel, Switzerland) (01-11-2023)
    “…Tumor heterogeneity leads to drug resistance in cancer treatment with the crucial role of sphingolipids in cell fate and stress signaling. We analyzed…”
    Get full text
    Journal Article
  7. 7

    Building a Personalized Cancer Treatment System by Martinez, Alexandra, López, Gustavo, Bola nos, Constantino, Alvarado, Daniel, Solano, Andrés, López, Mariana, Báez, Andrés, Quirós, Steve, Mora, Rodrigo

    Published in Journal of medical systems (01-02-2017)
    “…This paper reports the process by which a personalized cancer treatment system was built, following a user-centered approach. We give some background on…”
    Get full text
    Journal Article
  8. 8

    Síndrome de Stevens-Johnson en una paciente con prueba positiva de transformación linfocitaria by Carvajal-Elizondo, Mariela, Monge-Ortega, Olga Patricia, Chinchilla-Monge, Ricardo, Quiros, Steve

    “…Antecedentes: El síndrome de Stevens-Johnson es una reacción medicamentosa severa. Las sulfamidas se han asociado con reacciones medicamentosas,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles by Quiros, Steve, Roos, Wynand P., Kaina, Bernd

    Published in Cell cycle (Georgetown, Tex.) (01-01-2010)
    “…The DNA adduct O 6 -methylguanine (O 6 MeG) induced by environmental genotoxins and anticancer drugs is a highly mutagenic, genotoxic and apoptotic lesion…”
    Get full text
    Journal Article
  11. 11
  12. 12

    XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair by Roos, Wynand P., Frohnapfel, Larissa, Quiros, Steve, Ringel, Florian, Kaina, Bernd

    Published in Cancer letters (28-06-2018)
    “…Glioblastoma is the most frequent and aggressive form of high-grade malignant glioma. Due to the dismal prognosis faced by patients suffering from this…”
    Get full text
    Journal Article
  13. 13

    Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A2 by Carlos Santamaría, Silda Larios, Steve Quirós, Javier Pizarro-Cerda, Jean-Pierre Gorvel, Bruno Lomonte, Edgardo Moreno

    Published in Antimicrobial Agents and Chemotherapy (01-04-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O 6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs by Roos, Wynand P., Nikolova, Teodora, Quiros, Steve, Naumann, Steffen C., Kiedron, Olivia, Zdzienicka, Małgorzata Z., Kaina, Bernd

    Published in DNA repair (2009)
    “…O 6-methylguanine (O 6MeG) is a highly critical DNA adduct induced by methylating carcinogens and anticancer drugs such as temozolomide, streptozotocine,…”
    Get full text
    Journal Article
  15. 15

    Generación de Datos de Validación para Rastreo Celular en Microscopía de Campo Claro usando Muestras Fluorescentes by Quinde-Cobos, Patricia, Quirós, Steve, Siles-Canales, Francisco

    Published in Tecnología en marcha (27-03-2020)
    “…Este trabajo usa imágenes de fluorescencia de células cancerígenas como para validación de resultados obtenidos por segmentación de imágenes de campo claro de…”
    Get full text
    Journal Article
  16. 16

    Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs by Roos, Wynand P, Nikolova, Teodora, Quiros, Steve, Naumann, Steffen C, Kiedron, Olivia, Zdzienicka, Małgorzata Z, Kaina, Bernd

    Published in DNA repair (01-01-2009)
    “…O(6)-methylguanine (O(6)MeG) is a highly critical DNA adduct induced by methylating carcinogens and anticancer drugs such as temozolomide, streptozotocine,…”
    Get full text
    Journal Article
  17. 17

    B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells by Roos, Wynand P, Quiros, Steve, Krumm, Andrea, Merz, Stephanie, Switzeny, Olivier Jérôme, Christmann, Markus, Loquai, Carmen, Kaina, Bernd

    Published in Oncotarget (30-12-2014)
    “…In the treatment of metastatic melanoma, a highly therapy-refractory cancer, alkylating agents are used and, for the subgroup of BRAFV600E cancers, the B-Raf…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A sub(2) by Santamaria, Carlos, Larios, Silda, Quiros, Steve, Pizarro-Cerda, Javier, Gorvel, Jean-Pierre, Lomonte, Bruno, Moreno, Edgardo

    Published in Antimicrobial agents and chemotherapy (01-04-2005)
    “…The activities of short synthetic, nonhemolytic peptides derived from the C-terminal region of myotoxin II, a catalytically inactive phospholipase A sub(2)…”
    Get full text
    Journal Article